Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs60065367 | chr17:74663080 | T/C | 1.16E-6 | 170 | 25.53 | 24.37 | 10.28 | KM Plot |
PCPG | rs6006606 | chr22:44392658 | C/T | 0.00011 | 176 | 24.5 | 27.47 | 19.87 | KM Plot |
PCPG | rs60114386 | chr7:158688706 | G/T | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs60192809 | chr12:56701379 | G/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs60221713 | chr16:87327302 | C/T | 1.11E-16 | 170 | 23.03 | 30.63 | 2.22 | KM Plot |
PCPG | rs60242987 | chr17:65798891 | A/G | 0.000405 | 175 | 24.37 | 36 | 8.22 | KM Plot |
PCPG | rs60243223 | chr2:176180413 | T/C | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs60243961 | chr12:53502221 | C/CT | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs60375889 | chr2:176132099 | C/T | 0.000138 | 175 | 25.4 | 28.38 | 6.62 | KM Plot |
PCPG | rs6038330 | chr20:6001469 | G/A | 0 | 178 | 25.67 | 23.08 | 2.93 | KM Plot |
PCPG | rs60420669 | chr10:69788149 | A/G | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs60496800 | chr18:74538074 | AT/A | 6.2E-9 | 176 | 25.53 | 25.17 | 10.17 | KM Plot |
PCPG | rs6053834 | chr20:6006528 | A/C | 0 | 177 | 25.67 | 22.63 | 2.93 | KM Plot |
PCPG | rs6053835 | chr20:6011122 | A/G | 0 | 177 | 25.67 | 22.63 | 2.93 | KM Plot |
PCPG | rs60542959 | chr12:56660905 | G/T | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |